Another major strength of our study is the fact that PROM2 overexpression may not only be associated with metastatic processes in melanoma, but also with other cancer types, including clear‐cell renal cell carcinomas and triple‐negative breast cancers. This evidence concerns the gene PROM2 and cancer.